IL140412A0 - L-lys -l-glu dipeptides for pharmaceutical preparations - Google Patents

L-lys -l-glu dipeptides for pharmaceutical preparations

Info

Publication number
IL140412A0
IL140412A0 IL14041299A IL14041299A IL140412A0 IL 140412 A0 IL140412 A0 IL 140412A0 IL 14041299 A IL14041299 A IL 14041299A IL 14041299 A IL14041299 A IL 14041299A IL 140412 A0 IL140412 A0 IL 140412A0
Authority
IL
Israel
Prior art keywords
lys
proposed
stimulating
drug
pharmaceutical preparations
Prior art date
Application number
IL14041299A
Other languages
English (en)
Original Assignee
Obschestvo S Ogranichennoi Otv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obschestvo S Ogranichennoi Otv filed Critical Obschestvo S Ogranichennoi Otv
Publication of IL140412A0 publication Critical patent/IL140412A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Bending Of Plates, Rods, And Pipes (AREA)
IL14041299A 1998-06-23 1999-05-27 L-lys -l-glu dipeptides for pharmaceutical preparations IL140412A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU98111342/14A RU2139085C1 (ru) 1998-06-23 1998-06-23 Средство, стимулирующее репаративные процессы, и способ его применения
PCT/RU1999/000188 WO1999066948A2 (en) 1998-06-23 1999-05-27 Use of a dipeptide for stimulating repair processes

Publications (1)

Publication Number Publication Date
IL140412A0 true IL140412A0 (en) 2002-02-10

Family

ID=20207251

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14041299A IL140412A0 (en) 1998-06-23 1999-05-27 L-lys -l-glu dipeptides for pharmaceutical preparations
IL140412A IL140412A (en) 1998-06-23 2000-12-19 L-lys -l-glu dipeptides for pharmaceutical preparations

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL140412A IL140412A (en) 1998-06-23 2000-12-19 L-lys -l-glu dipeptides for pharmaceutical preparations

Country Status (11)

Country Link
US (1) US6642201B1 (ja)
EP (1) EP1089753B1 (ja)
JP (1) JP4489946B2 (ja)
AT (1) ATE245434T1 (ja)
AU (1) AU776693B2 (ja)
CA (1) CA2335362C (ja)
CH (1) CH692477A5 (ja)
DE (1) DE69909794T2 (ja)
IL (2) IL140412A0 (ja)
RU (1) RU2139085C1 (ja)
WO (1) WO1999066948A2 (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
EP1138692A1 (en) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments of human chorionic gonadotropin (hcg) as immunoregulator
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
RU2177801C1 (ru) * 2001-01-25 2002-01-10 Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" Средство, ингибирующее ангиогенез при заболеваниях органа зрения
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US7517529B2 (en) * 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
US20090191105A1 (en) * 2004-08-30 2009-07-30 Kazuhiro Tanahashi Fractionation Apparatus
WO2007004869A2 (en) * 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
EP1864692A1 (en) * 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
RU2301071C1 (ru) * 2006-06-22 2007-06-20 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Гепатопротекторное средство и способ его получения
WO2010086754A2 (en) * 2009-01-30 2010-08-05 Beiersdorf Ag Cosmetic or dermatological preparation comprising collagen, chitosan, glycosylaminoglycan and cell growth promoting peptide and/or cellular complex
EP2625577B1 (en) 2010-10-08 2019-06-26 Terumo BCT, Inc. Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
RU2496511C1 (ru) * 2012-04-20 2013-10-27 Замертон Холдингс Лимитед Фармацевтическая композиция, средство (варианты) и способ профилактики и лечения артрита, остеоартроза и остеохондроза позвоночника (варианты)
RU2517213C2 (ru) * 2012-08-03 2014-05-27 Татьяна Георгиевна Емельянова Средство пептидной структуры, обладающее противовоспалительным, антибактериальным, ранозаживляющим, регенеративным, анальгетическим, противоожоговым действием и лекарственные формы на его основе
RU2521973C1 (ru) * 2013-08-23 2014-07-10 Замертон Холдингс Лимитед Средства для профилактики и лечения заболеваний суставов и способы их применения
JP6633522B2 (ja) 2013-11-16 2020-01-22 テルモ ビーシーティー、インコーポレーテッド バイオリアクターにおける細胞増殖
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
EA025549B1 (ru) 2014-09-09 2017-01-30 Замертон Холдингс Лимитед Композиция и средства для профилактики и лечения заболеваний суставов и позвоночника и способы их применения
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
RU2627669C1 (ru) * 2016-07-20 2017-08-09 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Способ получения продуктов метаболизма бифидобактерий для лечения комбинированного радиационно-термического поражения организма и способ лечения комбинированного радиационно-термического поражения организма
EP3656841A1 (en) 2017-03-31 2020-05-27 Terumo BCT, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
CN113004370B (zh) * 2021-02-09 2022-06-17 宁波绿之健药业有限公司 一种具有缓解高尿酸血症和调节肠道菌群的二肽及其应用
US12043823B2 (en) 2021-03-23 2024-07-23 Terumo Bct, Inc. Cell capture and expansion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD248961A1 (de) * 1984-05-22 1987-08-26 Akad Wissenschaften Ddr Verfahren zur herstellung wundheilungsfoerdernder praeparationen
WO1995003067A1 (en) * 1993-07-21 1995-02-02 Khavinson Vladimir Khatskelevi Pharmaceutical with immunomodulating activity
RU2080120C1 (ru) * 1994-07-19 1997-05-27 Совместное русско-американское акционерное общество закрытого типа "Неофарм" Средство, обладающее иммуномодулирующей активностью

Also Published As

Publication number Publication date
RU2139085C1 (ru) 1999-10-10
JP2002518459A (ja) 2002-06-25
EP1089753A2 (en) 2001-04-11
AU776693B2 (en) 2004-09-16
CH692477A5 (de) 2002-07-15
AU4536999A (en) 2000-01-10
US6642201B1 (en) 2003-11-04
DE69909794T2 (de) 2004-06-09
EP1089753B1 (en) 2003-07-23
WO1999066948A3 (en) 2000-03-23
IL140412A (en) 2007-06-17
CA2335362A1 (en) 1999-12-29
ATE245434T1 (de) 2003-08-15
DE69909794D1 (de) 2003-08-28
CA2335362C (en) 2012-11-20
WO1999066948A2 (en) 1999-12-29
JP4489946B2 (ja) 2010-06-23

Similar Documents

Publication Publication Date Title
IL140412A0 (en) L-lys -l-glu dipeptides for pharmaceutical preparations
EP1033998A4 (en) METHOD FOR SUPPRESSING BETA AMYLOID-RELATED CHANGES IN ALZHEIMER
PL338982A1 (en) Drug for improving duration of muscle action or for treating muscular disorders or diseases
NZ508526A (en) Opioid formulations for treating pain
RU95113492A (ru) Терапевтическая комбинация, содержащая человеческий интерферон, его применение, фармацевтический препарат, упаковка и способ лечения
DE69634609D1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu-opioidanagonisten und eines kappa - 2- opioidanagonisten
IL146432A0 (en) A tetrapeptide and a pharmaceutical composition containing the same
MX9709644A (es) Dispositivo para el suministro transdermico por electrotransporte de fentanilo y sufentanilo.
BR9510168A (pt) Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
PT946151E (pt) Forma de dosagem de dose crescente
IL149243A0 (en) Tetrapeptide-l-alanyl-l-glutamyl-l-aspartyl-l-proline and its salts and pharmaceutical compositions containing the same
WO2001068125A3 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
IL136733A0 (en) Pharmaceutical composition containing sibutramine and orlistat
EA200700178A1 (ru) Пептид, обладающий стресспротекторным действием, фармацевтическая композиция на его основе и способ ее применения
EP1304108A3 (en) Anti-arrhythmic composition and methods of treatment
ATE513845T1 (de) Peptidsubstanz mit immunogeroprotektiver wirkung, darauf basierende pharmazeutische zusammensetzung und verfahren zu ihrer anwendung
YU60199A (sh) Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji
WO2007139433A8 (en) Peptide substance normalizing the metabolism in osseous and cartilaginous tissues, pharmaceutical composition on its base and the method of its application
CA2465667A1 (en) New peptides - analogs of human growth hormone-releasing hormone
WO2002030955A3 (en) Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
KR950704358A (ko) 카텝신 l 특이적 저해 폴리펩티드
Millinger Neutral amino acid therapy for the management of chronic pain
US20200339627A1 (en) Endomorphin-2, tetrapeptide derivatives thereof, and uses thereof
EA200601581A1 (ru) Пептид, стимулирующий регенерацию ткани печени, фармацевтическая композиция на его основе и способ ее применения

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed